ConductScience.org, home

Paper36938103

Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity.

Ackun-Farmmer MA and 1 other. Adv Nanobiomed Res, 2023. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity. Papers, record 36938103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36938103

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity.
PubMed
Journal
Adv Nanobiomed Res
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
2.3
iCite
Revised in PubMed
2024-09-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ackun-Farmmer MAMarian A
2Jewell CMChristopher M

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
I01 BX003690BLRD VAUnited StatesI01BX003690PubMed and NIHNIH RePORTER
R01 AI144667NIAID NIH HHSUnited StatesR01AI144667PubMed and NIHNIH RePORTER
R01 AI169686NIAID NIH HHSUnited StatesR01AI169686PubMed and NIHNIH RePORTER
R01 EB027143NIBIB NIH HHSUnited StatesR01EB027143PubMed and NIHNIH RePORTER

Download CSV of grants

References144

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121975206A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.Neurology2011https://conductscience.org/library/papers/21975206PubMed
27680493Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.Science1993https://conductscience.org/library/papers/7680493PubMed
326509048Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response.RMD Open2015https://conductscience.org/library/papers/26509048PubMed
428772190An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.Biomaterials2017https://conductscience.org/library/papers/28772190PubMed
528116870Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.Adv Healthc Mater2017https://conductscience.org/library/papers/28116870PubMed
624430972Intra-lymph node injection of biodegradable polymer particles.J Vis Exp2014https://conductscience.org/library/papers/24430972PubMed
734668580Tolerance induction by liposomes targeting a single CD8 epitope IGRP206-214 in a model of type 1 diabetes is impeded by co-targeting a CD4+ islet epitope.Immunol Cell Biol2022https://conductscience.org/library/papers/34668580PubMed
835359943Mapping the Mechanical and Immunological Profiles of Polymeric Microneedles to Enable Vaccine and Immunotherapy Applications.Front Immunol2022https://conductscience.org/library/papers/35359943PubMed
928199812Intralymphatic Injection of Autoantigen in Type 1 Diabetes.N Engl J Med2017https://conductscience.org/library/papers/28199812PubMed
1018688037Sex differences in autoimmune disease from a pathological perspective.Am J Pathol2008https://conductscience.org/library/papers/18688037PubMed
1133881872Biophysical Properties of Self-Assembled Immune Signals Impact Signal Processing and the Nature of Regulatory Immune Function.Nano Lett2021https://conductscience.org/library/papers/33881872PubMed
1235679343Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/35679343PubMed
139395124Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis.J Neurol Sci1997https://conductscience.org/library/papers/9395124PubMed
1433144616Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes.Sci Rep2020https://conductscience.org/library/papers/33144616PubMed
1511079539NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients.Ann Neurol2000https://conductscience.org/library/papers/11079539PubMed
1626348965Principles of nanoparticle design for overcoming biological barriers to drug delivery.Nat Biotechnol2015https://conductscience.org/library/papers/26348965PubMed
1729148731Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide- co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance.Bioconjug Chem2018https://conductscience.org/library/papers/29148731PubMed
1832209459Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity.Cell Rep2020https://conductscience.org/library/papers/32209459PubMed
1931119191Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model.ACS Biomater Sci Eng2019https://conductscience.org/library/papers/31119191PubMed
2033645967Exploiting Rational Assembly to Map Distinct Roles of Regulatory Cues during Autoimmune Therapy.ACS Nano2021https://conductscience.org/library/papers/33645967PubMed

See all 144 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42922362Physicochemical design principles for B cell targeted acetalated dextran microparticles in antigen-specific tolerance for multiple sclerosis.Biomater Sci2026https://conductscience.org/library/papers/42922362PubMed
42194053Plant-Derived Nanovesicles: A Comprehensive Review from Isolation to Clinical Translation-Unlocking Natural Nanocarriers for Biomedical Applications.Biomolecules2026https://conductscience.org/library/papers/42194053PubMed
41321036Antigen-Specific Inverse Vaccination Strategies Using Particle Systems for Multiple Sclerosis.ACS Biomater Sci Eng2026https://conductscience.org/library/papers/41321036PubMed
41316372Reprogramming autoimmunity: inducing antigen-specific tolerance via apoptotic mimicry in an experimental model of multiple sclerosis.J Neuroinflammation2025https://conductscience.org/library/papers/41316372PubMed
41280059Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis.bioRxiv2025https://conductscience.org/library/papers/41280059PubMed
41183200Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/41183200PubMed
41183192Structural immunotherapy: Harnessing chemical design to build powerful next-generation therapeutics.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/41183192PubMed
41172992Defined distribution and features of lymph node therapies enable recruitment and manipulation of antigen-specific T cell response.Mol Ther2026https://conductscience.org/library/papers/41172992PubMed
40182604From Edmonton to Lantidra and beyond: immunoengineering islet transplantation to cure type 1 diabetes.Front Transplant2025https://conductscience.org/library/papers/40182604PubMed
39520377Engineered Immune Constructs Alter Antigen-Specific Immune Tolerance and Confer Durable Protection in Myelin-Driven Autoimmunity.ACS Nano2024https://conductscience.org/library/papers/39520377PubMed
38670230Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/38670230PubMed
38342243Emerging strategies for nanomedicine in autoimmunity.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/38342243PubMed
38166244Rational Engineering of Islet Tolerance via Biomaterial-Mediated Immune Modulation.J Immunol2024https://conductscience.org/library/papers/38166244PubMed
37935318Engineering metabolism to modulate immunity.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/37935318PubMed
37877041Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/37877041PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36938103

GET https://conductscience.org/api/papers/v1/36938103/references?page=2